WallStreetZenWallStreetZen

NASDAQ: GOCO
Gohealth Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for GOCO

Based on 2 analysts offering 12 month price targets for Gohealth Inc

Min Forecast
$4.50+252.94%
Avg Forecast
$4.75+272.55%
Max Forecast
$5.00+292.16%

Should I buy or sell GOCO stock?

Based on 2 analysts offering ratings for Gohealth Inc.

Buy
Strong Buy
1 analysts 50%
Buy
0 analysts 0%
Hold
1 analysts 50%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their GOCO stock forecasts and price targets.

GOCO stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-11-26
lockedlocked$00.00+00.00%2025-11-20

1 of 1

Forecast return on equity

Is GOCO forecast to generate an efficient return?

Company
-263.88%
Industry
33.11%
Market
147.3%
GOCO's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is GOCO forecast to generate an efficient return on assets?

Company
-10.12%
Industry
8.51%
GOCO is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

GOCO earnings per share forecast

What is GOCO's earnings per share in the next 2 years based on estimates from 8 analysts?

Avg 1 year Forecast
-$5.28
Avg 2 year Forecast
-$3.46

GOCO revenue forecast

What is GOCO's revenue in the next 2 years based on estimates from 8 analysts?

Avg 1 year Forecast
$333.6M-7.82%
Avg 2 year Forecast
$633.9M+75.19%
GOCO's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

GOCO revenue growth forecast

How is GOCO forecast to perform vs Insurance Brokers companies and vs the US market?

Company
-7.82%
Industry
11.63%
Market
189.49%
GOCO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
GOCO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

GOCO vs Insurance Stocks

TickerPricePrice TargetUp/downsideConsensus
GOCO$1.28$4.75+272.55%Buy
EHTH$1.26$2.50+98.41%Hold
ZBAO$0.72N/AN/A
HUIZ$1.43N/AN/A
AIFU$1.47N/AN/A
View Top Insurance Stocks

Gohealth Stock Forecast FAQ

Is Gohealth Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: GOCO) stock is to Buy GOCO stock.

Out of 2 analysts, 1 (50%) are recommending GOCO as a Strong Buy, 0 (0%) are recommending GOCO as a Buy, 1 (50%) are recommending GOCO as a Hold, 0 (0%) are recommending GOCO as a Sell, and 0 (0%) are recommending GOCO as a Strong Sell.

If you're new to stock investing, here's how to buy Gohealth stock.

What is GOCO's earnings growth forecast for 2026-2027?

(NASDAQ: GOCO) Gohealth's forecast annual earnings growth rate of N/A is not forecast to beat the US Insurance Brokers industry's average forecast earnings growth rate of 43.26%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 1,641.54%.

Gohealth's earnings in 2026 is -$257,126,000.On average, 8 Wall Street analysts forecast GOCO's earnings for 2026 to be -$152,411,434, with the lowest GOCO earnings forecast at -$250,465,212, and the highest GOCO earnings forecast at $37,254,782.

In 2027, GOCO is forecast to generate -$99,940,316 in earnings, with the lowest earnings forecast at -$173,290,265 and the highest earnings forecast at $1,817,306.

What is GOCO's revenue growth forecast for 2026-2027?

(NASDAQ: GOCO) Gohealth's forecast annual revenue growth rate of -7.82% is not forecast to beat the US Insurance Brokers industry's average forecast revenue growth rate of 11.63%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 189.49%.

Gohealth's revenue in 2026 is $361,845,000.On average, 8 Wall Street analysts forecast GOCO's revenue for 2026 to be $9,621,627,996, with the lowest GOCO revenue forecast at $6,407,880,207, and the highest GOCO revenue forecast at $12,148,837,795.

In 2027, GOCO is forecast to generate $18,286,429,727 in revenue, with the lowest revenue forecast at $16,678,834,679 and the highest revenue forecast at $21,120,273,931.

What is GOCO's forecast return on assets (ROA) for 2026-2027?

(NASDAQ: GOCO) forecast ROA is -10.12%, which is lower than the forecast US Insurance Brokers industry average of 8.51%.

What is GOCO's Price Target?

According to 2 Wall Street analysts that have issued a 1 year GOCO price target, the average GOCO price target is $4.75, with the highest GOCO stock price forecast at $5.00 and the lowest GOCO stock price forecast at $4.50.

On average, Wall Street analysts predict that Gohealth's share price could reach $4.75 by Nov 26, 2026. The average Gohealth stock price prediction forecasts a potential upside of 272.55% from the current GOCO share price of $1.28.

What is GOCO's Earnings Per Share (EPS) forecast for 2026-2027?

(NASDAQ: GOCO) Gohealth's current Earnings Per Share (EPS) is -$20.17. On average, analysts forecast that GOCO's EPS will be -$5.28 for 2026, with the lowest EPS forecast at -$8.68, and the highest EPS forecast at $1.29. In 2027, GOCO's EPS is forecast to hit -$3.46 (min: -$6.01, max: $0.06).

What is GOCO's forecast return on equity (ROE) for 2026-2027?

(NASDAQ: GOCO) forecast ROE is -263.88%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.